Description: Don't overlook these REITs the next time you go stock shopping.
Description: Welltower (WELL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Description: Welltower (WELL) has been trading actively this month, with the stock showing steady gains of nearly 11% over the past month. Investors are watching to see how the company maintains momentum as ongoing sector developments unfold. See our latest analysis for Welltower. Welltower’s recent 10.8% 1-month share price return is part of a broader surge, as momentum has picked up impressively this year. Investors have enjoyed a 57.9% share price gain since January, while the total shareholder return...
Description: Welltower (WELL) is a $135 billion REIT focused on senior housing, healthcare, and outpatient facilities. Shares have strong technical momentum and are trading at a new all-time high. WELL stock is up 45% in the past year and over 50% in the year to date. Analyst sentiment is mostly positive,...
Description: Does Welltower (WELL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Description: WELL's stock momentum is fueled by strong SHO demand, major U.K. acquisitions and ample liquidity amid aging demographics.
Description: As Welltower has outperformed relative to the broader market over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.
Description: In the past week, Welltower Inc. completed a multi-billion dollar follow-on equity offering, made several key executive hires, and reported third-quarter 2025 earnings results showing higher revenues but lower net income year-over-year. Analyst coverage has focused on Welltower's sharpened pivot toward senior housing, with numerous upgrades and Buy reiterations reflecting confidence in the company's expanded investment and operational focus in this segment. We'll examine how Welltower’s...
Description: Welltower Inc. (NYSE:WELL) is one of the must-buy US stocks to buy now. On October 28, BMO Capital Markets analyst Juan Sanabria reiterated a Buy rating on Welltower Inc. (NYSE:WELL) stock and a $200 price target. The positive stance is in response to the company’s strong financial performance and strategic initiatives. The company delivered solid […]
Description: Tesla sets delivery records but braces for weaker Q4 as tax credits expire and competition heats up.
Description: Welltower (WELL) possesses solid growth attributes, which could help it handily outperform the market.
Description: MPW's Q3 results show higher revenues but lower NFFO per share as interest expenses weigh on performance.
Description: VTR posts strong Q3 results with higher FFO and revenues, fueled by gains in senior housing and outpatient medical portfolios.
Description: Welltower (WELL) reported a net profit margin of 9.7%, down from 12.1% the previous year, and posted earnings growth of 4.9% over the past year, trailing its 5-year average annual growth rate of 9.4%. Looking ahead, revenue is forecast to grow at 14.5% per year and earnings at 24.4% per year, both outpacing US market averages. Despite recent margin compression and a premium price-to-earnings ratio of 128x, investor focus is now turning to whether this outlook justifies the stock’s above-fair...
Description: WELL's Q3 FFO outshines estimates, driven by a rise in revenues. Same Store NOI improves year over year.
Description: Welltower (WELL) is positioning its portfolio for "sustained elevated" growth by divesting 68% of it
Description: Remedy Medical Properties ("Remedy") and Kayne Anderson Real Estate, together the nation's largest private owner of healthcare real estate, today announced the acquisition of a portfolio of outpatient medical (OM) assets from Welltower. The portfolio comprises approximately 18 million square feet across 296 properties in 34 states, and this acquisition establishes the Remedy and Kayne Anderson Real Estate partnership as the nation's largest owner of outpatient medical buildings, with more than 5
Description: The headline numbers for Welltower (WELL) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Description: Welltower (WELL) delivered FFO and revenue surprises of +3.08% and +1.36%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Description: Investing.com -- Welltower Inc (NYSE:WELL) reported third quarter normalized funds from operations (FFO) of $1.34 per share, representing a 20.7% increase from the same period last year, despite missing analyst expectations on earnings per share. The healthcare real estate investment trust’s shares dipped 0.7% in after-hours trading Monday.
Description: The real estate investment trust, based in Toledo, Ohio, said it had funds from operations of $919.2 million, or $1.34 per share, in the period. The average estimate of five analysts surveyed by Zacks Investment Research was for funds from operations of $1.30 per share. Funds from operations is a closely watched measure in the REIT industry.
Description: Welltower® Inc. (NYSE: WELL) has issued the following business update which can be found at:
Description: Welltower Announces a Transformative New Era to Maximize Long-Term Shareholder Returns
Description: Welltower Announces $23 Billion of Transactions and Intensified Focus on Seniors Housing to Amplify Long-Term Growth Profile
Description: Welltower Inc. (NYSE:WELL) today announced results for the quarter ended September 30, 2025.
Description: The market enters the fourth full week of the government shutdown with international trade and domestic rates in focus.
Description: Welltower Inc. (NYSE:WELL) is a real estate investment trust that invests in healthcare and seniors housing infrastructure, including properties for seniors housing, post-acute care, and outpatient medical services. It will report its Q3 2025 earnings ...
Description: Market Domination Overtime host Josh Lipton previews several of the biggest stories to come next week, including earnings results from Magnificent Seven companies Microsoft (MSFT), Amazon (AMZN), Apple (AAPL), Alphabet (GOOG, GOOGL), and Meta Platforms (META); Federal Reserve officials convening for their October FOMC meeting; and President Trump is meeting Chinese President Xi Jinping in South Korea as the government shutdown nears its fifth week. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime.
Description: Investors next week will tune into big-tech earnings and the first Federal Reserve meeting since the U.S. government shutdown began. Later in the week, President Trump is due to meet with Chinese leader Xi Jinping as trade tensions between the two economic giants simmer.
Description: DOC's third-quarter results reflect the continued strong performance of its high-quality outpatient medical and CCRC portfolios.
Description: DLR posts strong Q3 results and lifts its 2025 FFO outlook on robust leasing and rising enterprise demand.
Description: WELL's Q3 results are likely to shine on the increasing aging population and its healthcare expenditure, though high interest expenses could weigh on gains.
Description: Beyond analysts' top-and-bottom-line estimates for Welltower (WELL), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.